'Unwarranted opposition' to PMI’s transformation has negatively impacted the pharmaceutical company’s business, according to the multinational. Read More
Tags :Philip Morris Interantional
Recent Posts
- Italian Lawmakers Examine Tobacco Legislation
- UK Urged to Tackle Illegal Vapes
- Filtrona Expands Boreas Range
- Philippines Lowers Minimum Tobacco Prices
- Senate Insists on Exceptions to Ad Ban
- JT Extends Tender Offer to Acquire Vector
- British American Tobacco Launches ‘Omni’
- PMI Sells Vectura at a Loss
- BAT Announces Management Board Changes
- EU Wants to Ban Outdoor Smoking and Vaping
- New Zealand Cracks Down on Illegal Nicotine Sales
- Tax Hike Sparks ‘Chaos’ in Jordan Market
- ‘Vapes Lacking Health Labels on Social Media’
- Cigarette Seizures up in the Netherlands
- Malawi Tobacco Earnings up Despite Drought